Figure 5 | Scientific Reports

Figure 5

From: Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression

Figure 5

Proliferation assays after PAC, HZnO and FCPZnO treatment in (A) MCF-7, (B) MDA-MB-231 cells was measured using MTT assays. (C) Apoptotic activity of control, PAC, HZnO and FCPZnO-nanocarriers on MCF-7 and MDA-MB-231 cells by phase distribution study. Results are representative of three independent experiments.

Back to article page